Get started
Author

Hirofumi Kamada

Observed names: H. Kamada, Hirofumi KAMADA
Observed institution: Iwate Medical University
ORCID: 0000-0002-0092-3935
Observed ORCID: 0000-0002-0092-3935
OpenAlex ID: A5081266794
Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan
2025 · Wataru Sasaki, Ryo Saito, et al. · The Journal of Dermatology · 11
PDF
Nemolizumab‐induced exacerbation of atopic dermatitis
2024 · Hirofumi Kamada, Nobuyuki Arakawa, et al. · The Journal of Dermatology · 7
PDF
DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells
2022 · Hirofumi Kamada, Shinji Yasuhira, et al. · Journal of Investigative Dermatology · 7
Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis
2023 · Hirofumi Kamada, Nobuyuki Arakawa, et al. · European Journal of Dermatology · 6
Dual Interleukin-4/Interleukin-13 Blocker-induced Arthralgia Treated Successfully with Upadacitinib in a Patient with Atopic Dermatitis
2023 · Takayuki Tanji, Daisuke Watabe, et al. · Acta Dermato Venereologica · 3
PDF
Review of 20 cases of advanced mucosal melanoma
2025 · Mina ITO, Shinpei MIURA, et al. · Skin Cancer
A case of primary cutaneous apocrine carcinoma treated with Tamoxifen
2025 · Mio DAIDOJI, Shinpei MIURA, et al. · Skin Cancer
A case of scalp angiosarcoma that became chemotherapy－resistant but was controlled for a long time with repeated changes in treatment medication, and a summary of angiosarcoma in our department
2025 · Hirofumi KAMADA, Shimpei MIURA, et al. · Skin Cancer
Prevalence and risk factors for onychomycosis in acute care dermatology wards
2024 · Tsuyoshi Inoue, Daisuke Watabe, et al. · The Journal of Dermatology
Five cases of malignant melanoma in which new lesions appeared after anti－PD－1 antibody treatment but long－term survival was achieved with continued treatment
2024 · Hirofumi KAMADA, Shimpei MIURA, et al. · Skin Cancer
473 DUSP4-DUSP6 axis contributes to sustained ERK activity and high proliferation of the melanoma cells
2022 · H. Kamada, S. Yasuhira, et al. · Journal of Investigative Dermatology
PDF
ESDR473 - DUSP4-DUSP6 axis contributes to sustained ERK activity and high proliferation of the melanoma cells.
2022 · Hirofumi Kamada, Shinji Yasuhira, et al.
Works count: 12
Citation count: 34
H-index: 4
I10-index: 1
Year
Topic
Type